Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

IRB Advisor

RSS  

Articles

  • Compassionate use of investigational drugs requires IRB approval, regs say

    The question remains: Is full-panel review necessary?
  • Protocols involving oral history still need review

    IRB members who are confused about whether research containing an oral history is subject to IRB review are not alone. The Office for Human Research Protections (OHRP) has written two letters on the matter, leaving some room for contradictory interpretation until guidelines are issued, possibly this year.
  • IRB role at small colleges sometimes a little murky

    Small colleges and undergraduate departments at universities are finding it increasingly important to formalize their human subject protection programs while making certain IRBs are reviewing what they should and not filling agendas with a lot of unnecessary reviews, several experts say.
  • ORI seeking educational program proposals

  • Training needs can be met with a variety of tools

    Human subjects training is typically a part of human subjects protections programs. Such training has taken the form of in-house seminars given at regular intervals and web-based activities. Regardless of the form, the objectives are simple: Give those involved in human subject research ethics and regulatory information that will promote beneficence and compliance with regulations.
  • Public outcry, confusion stops an Oregon study

    A 1999 National Institutes of Health-sponsored project to evaluate the results of a drug-testing program in Oregon public high schools was ultimately suspended after the federal Office for Human Research Protections (OHRP) decided that the goals of the research protocol appeared to have become intertwined with the drug-testing policy it was intended to study.
  • No need to panic when OHRP comes a calling

    Its a rare occurrence, but each year some institutions are subjected to a for-cause audit by the Office for Human Research Protections (OHRP). Such audits often turn up documentation problems and review process problems with the IRB, but occasionally they also highlight very serious problems relating to the clinical trials management, such as failure to provide adequate informed consent or failure to seek an IRB review, according to OHRP officials.
  • Should IRB regulations be tweaked or revised?

    Human subjects research protection experts agree that IRBs are overburdened and that something should be done to improve the regulations and rules governing their work. However, there is less agreement on how this could be accomplished. IRB Advisor asked IRB and research professionals to discuss how IRB regulations or the interpretation of them might be improved.
  • UPenn creates integrated clinical research program

    For the University of Pennsylvania School of Medicine in Philadelphia, there was no question that the only acceptable solution to the problems in human subjects research was to establish a comprehensive program that included all areas, including investigators, IRBs, and the institutions leadership.
  • Socio-behavioral studies sometimes offer fewer risks

    IRBs need to be aware that the tools and data collection techniques used in socio-behavioral research may appear riskier than they actually are, and the public benefits may be greater; therefore, its a good idea to refrain from categorically rejecting research that involves unknown factors, suggests John Laub, PhD, a professor of criminology and criminal justice at the University of Maryland in College Park.